$EPAM stock has now fallen 20% today, according to our price data from Polygon. There has been approximately $37,312,676 of trading volume.
It has been the 291st most-searched ticker on Quiver Quantitative over the last day, out of 10,940 total tickers searched.
Here is what we see in our data on $EPAM (you can track the company live on Quiver's $EPAM stock page):
$EPAM Insider Trading Activity
$EPAM insiders have traded $EPAM stock on the open market 13 times in the past 6 months. Of those trades, 7 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $EPAM stock by insiders over the last 6 months:
- SERGEY YEZHKOV (SVP/Co-Head of Global Business) has made 0 purchases and 2 sales selling 11,590 shares for an estimated $1,747,575.
- BORIS SHNAYDER (SVP/Co-Head of Global Business) has made 1 purchase buying 55 shares for an estimated $7,499 and 1 sale selling 5,000 shares for an estimated $1,035,000.
- VIKTAR DVORKIN (SVP/Head of Global Delivery) has made 1 purchase buying 55 shares for an estimated $7,499 and 2 sales selling 2,500 shares for an estimated $454,497.
- GARY C ABRAHAMS (VP, Corporate Controller, PAO) has made 1 purchase buying 55 shares for an estimated $7,499 and 1 sale selling 600 shares for an estimated $107,574.
- BALAZS FEJES (CEO, President, Director) purchased 55 shares for an estimated $7,499
- LAWRENCE F SOLOMON (SVP & Chief People Officer) purchased 55 shares for an estimated $7,499
- JASON D. PETERSON (Chief Financial Officer) purchased 55 shares for an estimated $7,499
- EDWARD ROCKWELL (SVP/General Counsel) purchased 55 shares for an estimated $7,499
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EPAM Hedge Fund Activity
We have seen 314 institutional investors add shares of $EPAM stock to their portfolio, and 359 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BOSTON PARTNERS added 1,704,768 shares (+inf%) to their portfolio in Q4 2025, for an estimated $349,272,867
- CAPITAL WORLD INVESTORS added 1,371,557 shares (+59.4%) to their portfolio in Q4 2025, for an estimated $281,004,598
- CITADEL ADVISORS LLC removed 1,286,924 shares (-93.4%) from their portfolio in Q4 2025, for an estimated $263,664,989
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 841,922 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $126,953,418
- FIL LTD added 713,596 shares (+inf%) to their portfolio in Q4 2025, for an estimated $146,201,548
- PRICE T ROWE ASSOCIATES INC /MD/ added 701,500 shares (+849.3%) to their portfolio in Q4 2025, for an estimated $143,723,320
- BARCLAYS PLC removed 615,524 shares (-88.1%) from their portfolio in Q4 2025, for an estimated $126,108,557
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$EPAM Analyst Ratings
Wall Street analysts have issued reports on $EPAM in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 11/07/2025
- Wells Fargo issued a "Overweight" rating on 10/22/2025
To track analyst ratings and price targets for $EPAM, check out Quiver Quantitative's $EPAM forecast page.
$EPAM Price Targets
Multiple analysts have issued price targets for $EPAM recently. We have seen 7 analysts offer price targets for $EPAM in the last 6 months, with a median target of $225.0.
Here are some recent targets:
- Bryan Keane from Citigroup set a target price of $225.0 on 01/29/2026
- Jason Kupferberg from Wells Fargo set a target price of $247.0 on 01/14/2026
- Bryan Bergin from TD Cowen set a target price of $243.0 on 01/09/2026
- Arvind Ramnani from Truist Securities set a target price of $220.0 on 01/06/2026
- Sean Kennedy from Mizuho set a target price of $228.0 on 11/11/2025
- Tien-Tsin Huang from JP Morgan set a target price of $215.0 on 11/07/2025
- James Faucette from Morgan Stanley set a target price of $175.0 on 09/09/2025
You can track data on $EPAM on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
